BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33022587)

  • 1. Prevalence And Impact Of Myofascial Pain Syndrome In Relapsing-Remitting Multiple Sclerosis And The Effects Of Local Anesthetic Injections For Short-Term Treatment.
    Tutuncu M; Ertem DH; Soysal A
    Mult Scler Relat Disord; 2020 Nov; 46():102528. PubMed ID: 33022587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
    Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
    Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study.
    de Sèze J; Devy R; Planque E; Delabrousse-Mayoux JP; Vandhuick O; Kabir M; Gherib A
    Mult Scler Relat Disord; 2021 Jan; 47():102659. PubMed ID: 33291032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study.
    Ata E; Kösem M; Adiguzel E
    J Back Musculoskelet Rehabil; 2019; 32(3):471-477. PubMed ID: 30507559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
    Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ashi Acupuncture Versus Local Anesthetic Trigger Point Injections in the Treatment of Abdominal Myofascial Pain Syndrome: A Randomized Clinical Trial.
    Mitidieri AMS; Baltazar MCDV; da Silva APM; Gurian MBF; Poli-Neto OB; Candido-Dos-Reis FJ; Nogueira AA; Rosa-E-Silva JC
    Pain Physician; 2020 Sep; 23(5):507-518. PubMed ID: 32967393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pulsed electromagnetic field therapy on fatigue, walking performance, depression, and quality of life in adults with multiple sclerosis: a randomized placebo-controlled trial.
    Granja-Domínguez A; Hochsprung A; Luque-Moreno C; Magni E; Escudero-Uribe S; Heredia-Camacho B; Izquierdo-Ayuso G; Heredia-Rizo AM
    Braz J Phys Ther; 2022; 26(5):100449. PubMed ID: 36283240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
    Fricska-Nagy Z; Füvesi J; Rózsa C; Komoly S; Jakab G; Csépány T; Jobbágy Z; Lencsés G; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2016 May; 7():26-32. PubMed ID: 27237753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    BMC Neurol; 2024 Feb; 24(1):51. PubMed ID: 38297247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trigger point injections vs. jet injection in the treatment of myofascial pain.
    Ready LB; Kozody R; Barsa JE; Murphy TM
    Pain; 1983 Feb; 15(2):201-6. PubMed ID: 6844028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial.
    Khodaie F; Naser Moghadasi A; Kazemi AH; Zhao B
    Acupunct Med; 2023 Aug; 41(4):199-205. PubMed ID: 36722418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.
    Foo EC; Russell M; Lily O; Ford HL
    Mult Scler Relat Disord; 2020 Sep; 44():102330. PubMed ID: 32599468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R; Piatkowski J; Ziemssen T
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis.
    Affaitati G; Costantini R; Tana C; Lapenna D; Schiavone C; Cipollone F; Giamberardino MA
    J Headache Pain; 2018 Nov; 19(1):104. PubMed ID: 30409108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.